12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Deals

Biocartis, bioMerieux deal

The companies mutually agreed to terminate a November 2010 deal to co-develop assays on Biocartis' Idylla (formerly Apollo) molecular diagnostics system. Biocartis regained all rights relating to the use...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >